Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interstitial Fibrosis in Protocol Biopsies of Renal Allografts: Sirolimus versus Cyclosporine
2004-004115-38Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- Dec 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of sirolimus and cyclosporine in end-stage kidney disease (ESKD) and Kidney allograft status (RTx) (2 arms), sponsored by Antwerp University Hospital. Primary endpoint: Cortical fractional interstitial fibrosis volume at 6 months. Started Dec 2005; status: completed.
02
Drugs
sirolimuscyclosporine
03
Conditions
end-stage kidney disease (ESKD)Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2004-004115-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004115-38.